Information Collection

Designation of New Animal Drugs for Minor Use and MInor Species ( MUMS)

IC 181664 under ICR 202211-0910-011 · OMB 0910-0605.

⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0605 can be found here:

Documents and Forms

Documents and forms in this information collection
Document Name	Document Type
Mock Up 0910-0605 ONADE eSubmitter Screen Shots 12-12-22.docx	Other-Electronic landing page
Mock Up 0910-0605 ONADE eSubmitter Screen Shots 12-12-22.docx	Other-Electronic landing page

IC Title:

Designation of New Animal Drugs for Minor Use and MInor Species ( MUMS)

Agency IC Tracking Number:

CVM

Is this a Common Form? No

IC Status: Modified

Obligation to Respond: Required to Obtain or Retain Benefits

CFR Citation: 21 CFR 516.26 21 CFR 516.27 21 CFR 516.29 21 CFR 516.20 21 CFR 516.30 21 CFR 516.36

Information Collection Instruments:

table that charts list of instruments
Document Type	Form No.	Form Name	Instrument File	URL	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Other-Electronic landing page					Yes	Yes	Fillable Fileable

Line of Business: Health

Subfunction: Consumer Health and Safety

Privacy Act System of Records

Title:

FR Citation:

Number of Respondents: 26

Number of Respondents for Small Entity: 0

Affected Public: Private Sector

Private Sector: Businesses or other for-profits

Percentage of Respondents Reporting Electronically: 100 %

table that charts list of burden
	Approved	Change Due to Adjustment in Agency Estimate	Previously Approved
Annual Number of Responses for this IC	69	-88	157
Annual IC Time Burden (Hours)	276	-1,086	1,362
Annual IC Cost Burden (Dollars)	0	0	0

Documents for IC

table that charts IC Documents
Title	Document	Date Uploaded
No associated records found

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.

Something went wrong when downloading this file. If you have any questions, please send an email to [email protected].